Barclays’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15	Closed	-$417	–	5228
2025 Q3	$417	Sell	15 -15,586	-100%	-$394K	﹤0.01%	5214
2025 Q2	$380K	Sell	15,601 -20,774	-57%	-$455K	﹤0.01%	3911
2025 Q1	$755K	Buy	36,375 +14,375	+65%	+$361K	﹤0.01%	3272
2024 Q4	$518K	Sell	22,000 -263,108	-92%	-$6.48M	﹤0.01%	3801
2024 Q3	$7.3M	Buy	285,108 +204,283	+253%	+$5.2M	﹤0.01%	1732
2024 Q2	$1.9M	Sell	80,825 -60,410	-43%	-$1.52M	﹤0.01%	2189
2024 Q1	$4.06M	Buy	141,235 +133,341	+1,689%	+$4.01M	﹤0.01%	2006
2023 Q4	$259K	Sell	7,894 -44,226	-85%	-$1.2M	﹤0.01%	4302
2023 Q3	$1.45M	Buy	52,120 +51,060	+4,817%	+$1.67M	﹤0.01%	2088
2023 Q2	$36.1K	Hold	1,060	–	–	﹤0.01%	3968
2023 Q1	$31.9K	Sell	1,060 -1,389	-57%	-$43K	﹤0.01%	4554
2022 Q4	$69.1K	Sell	2,449 -8,896	-78%	-$282K	﹤0.01%	4424
2022 Q3	$373K	Sell	11,345 -47,060	-81%	-$1.73M	﹤0.01%	2861
2022 Q2	$1.84M	Buy	58,405 +8,800	+18%	+$308K	﹤0.01%	1906
2022 Q1	$2.28M	Buy	49,605 +2,454	+5%	+$117K	﹤0.01%	1770
2021 Q4	$2.89M	Buy	47,151 +37,410	+384%	+$2.59M	﹤0.01%	2123
2021 Q3	$728K	Buy	9,741 +210	+2%	+$17.6K	﹤0.01%	2976
2021 Q2	$882K	Sell	9,531 -560	-6%	-$47.6K	﹤0.01%	2737
2021 Q1	$896K	Buy	10,091 +1,560	+18%	+$155K	﹤0.01%	2841
2020 Q4	$796K	Buy	+8,531	New	+$680K	﹤0.01%	2921